229 related articles for article (PubMed ID: 8988028)
1. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
London F; Ahmad SS; Walsh PN
Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
[TBL] [Abstract][Full Text] [Related]
2. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.
London F; Walsh PN
Biochemistry; 1996 Sep; 35(37):12146-54. PubMed ID: 8810922
[TBL] [Abstract][Full Text] [Related]
3. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa.
Scandura JM; Walsh PN
Biochemistry; 1996 Jul; 35(27):8903-13. PubMed ID: 8688426
[TBL] [Abstract][Full Text] [Related]
4. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
Wong MY; Gurr JA; Walsh PN
Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
[TBL] [Abstract][Full Text] [Related]
5. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
[TBL] [Abstract][Full Text] [Related]
7. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
Sheehan JP; Kobbervig CE; Kirkpatrick HM
Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
[TBL] [Abstract][Full Text] [Related]
8. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
Scandura JM; Ahmad SS; Walsh PN
Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study.
Hoffman M; Monroe DM; Roberts HR
Thromb Haemost; 1992 Jul; 68(1):74-8. PubMed ID: 1514177
[TBL] [Abstract][Full Text] [Related]
10. The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor-X activation.
Ahmad SS; Rawala R; Cheung WF; Stafford DW; Walsh PN
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):427-31. PubMed ID: 7654178
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
12. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
[TBL] [Abstract][Full Text] [Related]
13. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
Gilbert GE; Arena AA
Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
[TBL] [Abstract][Full Text] [Related]
14. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa.
London FS; Marcinkiewicz M; Walsh PN
J Biol Chem; 2004 May; 279(19):19854-9. PubMed ID: 15010476
[TBL] [Abstract][Full Text] [Related]
15. Comparative platelet binding and kinetic studies with normal and variant factor IXa molecules.
Ahmad SS; Rawala-Sheikh R; Monroe DM; Roberts HR; Walsh PN
J Biol Chem; 1990 Dec; 265(34):20907-11. PubMed ID: 2249997
[TBL] [Abstract][Full Text] [Related]
16. Platelet receptor occupancy with factor IXa promotes factor X activation.
Ahmad SS; Rawala-Sheikh R; Walsh PN
J Biol Chem; 1989 Nov; 264(33):20012-6. PubMed ID: 2555339
[TBL] [Abstract][Full Text] [Related]
17. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
Yang X; Chang YJ; Lin SW; Walsh PN
J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
[TBL] [Abstract][Full Text] [Related]
18. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
19. Comparative interactions of factor IX and factor IXa with human platelets.
Ahmad SS; Rawala-Sheikh R; Walsh PN
J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
[TBL] [Abstract][Full Text] [Related]
20. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Ahmad SS; Walsh PN
Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
